Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.416EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.416ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.416ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.416EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.416EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.416ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.416ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.63EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.63ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.63ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.63EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.63EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.263EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.263ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.263ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.263EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.263EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.263ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.263ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.135EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.135EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.135ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.135ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.135EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.135EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.135ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.135ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.5 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.43.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.5 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.43.5 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.43.5 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.43.5 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.43.5 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.5 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XBC.1.6.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1.6.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.1.6.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1.6.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used